OPHTHALMOLOGY

Macular Telangiectasia Type 1: Capillary Density and Microvascular Abnormalities Assessed by Optical Coherence Tomography Angiography

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Macular Telangiectasia Type 1: Capillary Density and Microvascular Abnormalities Assessed by Optical Coherence Tomography Angiography

Purpose To describe microvascular abnormalities and capillary density in macular telangiectasia type 1 (MT1) using optical coherence tomography angiography (OCTA), and correlate them with fluorescein angiography (FA). Design Observational case series….

read more

Retinal Ganglion Cell Layer Change in Patients Treated With Anti–Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Retinal Ganglion Cell Layer Change in Patients Treated With Anti–Vascular Endothelial Growth Factor for Neovascular Age-related Macular Degeneration

Purpose To evaluate macular retinal ganglion cell thickness in patients with neovascular age-related macular degeneration (AMD) and intravitreal anti–vascular endothelial growth factor (VEGF) therapy. Design Retrospective case series with fellow-eye…

read more

Long-Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Persistent Neovascular Age-Related Macular Degeneration

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Long-Term Results of Pro Re Nata Regimen of Aflibercept Treatment in Persistent Neovascular Age-Related Macular Degeneration

Purpose To determine the 24-month results of patients who had pro re nata (PRN) aflibercept treatment owing to recurrent or resistant neovascular macular degeneration. Design Retrospective, interventional, consecutive case series….

read more

Reporting Visual Acuities

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Reporting Visual Acuities

The AJO encourages authors to report the visual acuity in the manuscript using the same nomenclature that was used in gathering the data provided they were recorded in one of…

read more

Reply

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We thank Drs Uzun and Pehlivan for the comments. We have excluded individuals who have significant systemic diseases that could affect their visual performance, and this includes those with multiple…

read more

Reply

Jan 6, 2017 by in OPHTHALMOLOGY Comments Off on Reply

We thank Drs Hafezi and Kling for their comments regarding our recent publication. Despite intensive medical treatment being used, moderate to severe infectious keratitis usually leads to visual loss. The…

read more
Get Clinical Tree app for offline access